Surveillance Process for Industry: Monitoring Pharmacopoeia Revisions (PDF)

December 15, 2019
J. Mark Wiggins

J. Mark Wiggins is owner and compendial consultant with Global Pharmacopoeia Solutions LLC.

,
Joseph A. Albanese

Joseph A. Albanese is the director of Analytical Strategy and Compliance at Janssen Research and Development, LLC.

An effective surveillance program for monitoring the activities of pharmacopoeias around the world requires processes, people, and tools from across a company.